genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Special Report
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Cancer
Alpine’s Gold Standard Approach to Drug Development
Biomarkers
Precision M&A: Invitae Eyes Growth in Personalized Cancer Tests, Services with…
Gene Therapy
Obsidian’s SWFT Response to COVID-19
Antibody Drug Conjugates
AbCellera’s CEO: Flattening the Curve of Technology Development
Cancer
After Final Medicare LCD from Palmetto GBA, OncoCyte Pursues Private Coverage…
News
Alzheimers
New Method for Treating Myelin Disorders Discovered
Cancer
Novel Liver Cancer Mechanism Controls Development of Disease
Diabetes
Ultrafast, Stable Insulin Developed Thanks to Some “Magic Fairy Dust” Polymer…
CRISPR-Cas9
CRISPR Tool, in “CARPID Diem” Spirit, Detects RNA-Protein Interactions in Living…
Cancer
Chemotherapy Can Trigger Blood Vessel Anomalies Leading to Drug Resistance
Insights
All
Trends for 2020
Gene Therapy
Moving Forward after Two Deaths in a Gene Therapy Trial of…
Bioprocessing
Bioprocess 4.0 Approach Will Help Biopharma Achieve Regulators’ Goals
Bioprocessing
Digitalized Twin Model of the Workhorse
Bioprocessing
Mitigating Viral Contamination, a Challenge for Emerging Therapies
A-Lists
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Drug Discovery
Top 15 Best-Selling Drugs of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Gene Therapy
Moving Forward after Two Deaths in a Gene Therapy Trial of…
Cancer
Novel Liver Cancer Mechanism Controls Development of Disease
CRISPR-Cas9
CRISPR Tool, in “CARPID Diem” Spirit, Detects RNA-Protein Interactions in Living…
Cancer
Chemotherapy Can Trigger Blood Vessel Anomalies Leading to Drug Resistance
Magazine
All
Special Report
June 2020 Vol. 40 No. 6
The Human Genome Project in 2020 Hindsight
Commentary
3D Microscopy Keeps Getting Faster, Smarter, Leaner
Roundtable
Perspectives on Microscopy
Bioprocessing
Biomanufacturers Cope with Challenges of Going Continuous
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
eBooks
IsoPlexis’ Unique, Predictive Biology
eBooks
Engineering the Immune Response for Therapeutic Success
Upcoming Webinars
Packaging and Producer Cell Lines for Scalable Lentiviral Production
CRISPR-Cas9
GENcast: CRISPR Screens Speed Drug Discovery Efforts for Disease Intervention
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Therapeutics
Combination Therapies
Combination Therapies
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Combination Therapies
Combo Therapy Efficiently Creates Enduring Memory T Cells
Combination Therapies
Regeneron, Sanofi Launch Clinical Trial of Kevzara as Coronavirus Treatment
Combination Therapies
Supercharged Cancer Cells Outrun Chemo, Race toward Immunotherapy
Combination Therapies
Melanoma Checkpoint Therapy More Potent in Combination with Nanovaccine
Combination Therapies
Superbugs Thought to be Invincible Can Succumb to Antibiotic Combinations
Combination Therapies
Skin Cancer Risk Reduced by Topical Immunotherapy
Combination Therapies
FDA Approves Tecentriq-Abraxane Combo as First Immunotherapy Regimen for Breast Cancer
Combination Therapies
Merck KGaA, Pfizer Join BioXcel-Nektar Collaboration, Creating Triple Combination Therapy for...
Combination Therapies
Breast Cancer Fight Gets Aid from Immunotherapy and Diabetes Drug Combo
Combination Therapies
Conjoined Cells Form a Potent Immunotherapy Combo
Combination Therapies
Breast Cancer Trial: First-Line Chemo-Immuno Combo Improves Outcomes
Combination Therapies
Melanoma Immunotherapy Most Effective in Older Patients
Combination Therapies
Exhausted T Cells Come in Different Flavors
Combination Therapies
Anticancer Virotherapy May Be Better If Backed by Natural Killer Overkill
Combination Therapies
Personalized Cancer Vaccine Shows Promise in Patients with Advanced Ovarian Cancer
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Firm is also stopping clinical trials with this PAH medication.[olly-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesDec2010Dec10_2010_10596613_GirlInHospitalBedwithHCP_PfizerPullsThelinfromMarket1841495821-324x160.jpg "Breast Cancer Trial: First-Line Chemo-Immuno Combo Improves Outcomes")
![Disease-specific features of exhausted T cells have been revealed by epigenomic-guided mass cytometry profiling. Exhausted T cells have poor function in chronic infections and cancer but can be therapeutically reinvigorated. [John Wherry/Perelman School of Medicine at the University of Pennsylvania]](https://www.genengnews.com/wp-content/uploads/2018/08/May15_2018_UPenn_ExhaustingTCells2341811716-324x160.jpg "Exhausted T Cells Come in Different Flavors")
